International Scholarly Research Notices / 2012 / Article / Tab 1

Clinical Study

Sex Differences in the Effects of Inhaled Corticosteroids on Weight Gain among Patients with Asthma

Table 1

Patient demographics.

CharacteristicsWomen Men Percentage of missing information (n)

Sociodemographics
𝑛 #109710 (0)
 Age, yr#51.4 ± 13.548.3 ± 13.52 (4)
 White race, % (n)94 (100)91 (64)2 (4)
 Education, yr#12.9 ± 3.413.4 ± 3.74 (7)
 Employed, % (n)64 (66)73 (51)4 (7)
 Cohabitating, % (n)65 (67)70 (49)4 (7)
 Weight, kg#67.5 ± 1587.2 ± 19.32 (4)
 Baseline BMI, kg/m226 ± 5.428.1 ± 6.32 (4)
Pulmonary function
 FEV1, % predicted#78.0 ± 19.576.2 ± 21.57 (13)
 FVC, % predicted#88.0 ± 16.389.0 ± 20.28 (14)
 FEV1/FVC, % predicted72.6 ± 10.769.3 ± 10.18 (14)
Asthma history
  Asthma control (ACQ level)1.5 ± 1.11.4 ± 0.92 (4)
  Atopic#, % (n)69 (72)70 (49)3 (5)
Asthma medications
  Short-acting β 2-agonists#, % (n)96 (102)100 (70)2 (4)
  Long-acting β 2-agonists#, % (n)83 (88)74 (52)2 (4)
  ICS#, % (n)100 (106)99 (69)2 (4)
  ICS dose*#, μg776 ± 568716 ± 46014 (25)
  Oral corticosteroids#, % (n)
13 (14)6 (4)2 (4)
  Antileukotrienes#, % (n)15 (16)10 (7)2 (4)
  Antirhinitics#, % (n)25 (27)14 (10)2 (4)

Data are presented as mean ± SD or % (no.).
FEV: forced expiratory volume; FVC: forced vital capacity; ICS: inhaled corticosteroids.
*Fluticasone propionate equivalent (μg).
#Used in the multiple imputation process.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.